• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Multiple Myeloma

The AJMC® Multiple Myeloma compendium is a comprehensive resource for clinical news and expert insights for this cancer.

Latest News

FDA approval | Image Credit: © Surendra-stock.adobe.com
FDA Green-Lights D-VRd Quadruplet for Newly Diagnosed Multiple Myeloma

January 27th 2026

This approval brings the total indications for daratumumab and hyaluronidase to 5 in newly diagnosed disease and its 12th overall.

Roberto Mina, MD, Winship Cancer Institute of Emory University
Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD

January 23rd 2026

Nashville | Image Credit: © f11photo-stock.adobe.com
Advancing Biomarker Testing Across GU, Lung, and Myeloma Care

January 22nd 2026

FDA | Image Credit: © Pakin-stock.adobe.com
FDA Draft Guidance Proposes CR, MRD to Accelerate MM Drug Approval

January 21st 2026

Teclistamab | Image Credit: ©luchschenF-stock.adobe.com
MajesTEC-9 Data Add to Accolades for Teclistamab in Multiple Myeloma

January 15th 2026

Latest CME Events & Activities

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

View More

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

1.5 Credits / Hematologic Cancer, Hematology, Oncology

View More

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

2.0 Credits / Hematologic Cancer, Oncology

View More

Payment for Pharmacist Services: 2025 Update

1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law

View More

<1
...
1011121314
© 2026 MJH Life Sciences
AJMC®
All rights reserved.